After “Peculiar” Turns, Abbvie Loses Patent Claim For Humira In India

 
• By Vikas Dandekar
  
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from India

More from Focus On Asia